-
East Africa: Easy-to-Swallow Anti-Aids Drug for East Africa’s Children
Medics also hope the formulation, developed by pharmaceutical company Cipla, in collaboration with the Drugs for Neglected Diseases Initiative (DNDi) and was approved for use by WHO in 2015, will address the treatment gaps that currently exist as a result of challenges resulting from the way the current drugs are stored.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Not easy selling insurance to the bottom of the pyramid, even at $1 a month
The majority of Tanzania’s low-income and informal workers do not have access to insurance and struggle to pay for health services. Entrepreneur Lilian Makoi, co-founder of technology company Edgepoint, last year unveiled Jamii (previously named bimaAFYA) – a health insurance product users can buy for as little as $1 a month.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Report: Red Cross Spent 25 Percent Of Haiti Donations On Internal Expenses
The report also says the charity's top officials stonewalled congressional investigators and released incomplete information about its Haiti program to the public. It concludes "there are substantial and fundamental concerns about [the Red Cross] as an organization."The report also says the charity's top officials stonewalled congressional investigators and released incomplete information about its Haiti program to the public.
- Categories
- Health Care
- Region
- Latin America
-
‘Disease outbreak guarantees’—A proposed mechanism for enhancing public health capacity
The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.
- Categories
- Health Care
-
New Tool to Diagnose Zika
A Boston University researcher is on the team that created a prototype for a simple new test.
- Categories
- Health Care
-
The Economics of Antibiotic Resistance
The business model for developing new antibiotics is broken, researchers say. The question is, can we make a new one that works?
- Categories
- Health Care
- Tags
- public health
-
In the lab: six innovations scientists hope will end malaria
After being abandoned as too ambitious in 1969, global plans to eliminate malaria are back on the agenda, with financial backing from the world's richest couple, Bill and Melinda Gates, and U.S. President Barack Obama.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- research
-
Analytical chemists schooled on drug development
Glaxo Smith Kline (GSK) Pharmaceutical Company has started a one week training workshop for African analytical chemists to equip them with practical skills in Gas Chromatography-Mass Spectrometry (GC-MS).
- Categories
- Health Care
- Region
- Sub-Saharan Africa